Bio Protocol said NeuroLab AI, a project built by NootropicsDAO, will begin its Ignition Sale on the Bio Protocol platform at 14:00 UTC on Sept. 16, with NDT as the token being offered. The sale will run for two weeks. Participation requires staking USDC, with users also able to pair their position with BioXP. According to Bio Protocol, NeuroLab AI is designed to predict the potential effects of compounds on the brain and link molecular interactions with cognitive-equivalent effects, with the stated goal of helping researchers decide which candidates should move to the next round of lab testing. The project said its knowledge graph has organized more than 150,000 entries and over 8 million relationships. The initial raise is set at $200,000, with a starting fully diluted valuation of $3 million and initial project funding of $100,000. Bio Protocol added that participant allocations will be 100% unlocked at claim, with no lock-up and no linear vesting. veBIO holders will receive a 20% allocation and can claim at any time, though any unvested portion is forfeited upon claiming. Of that allocation, 20% is unlocked at TGE and the remainder will vest linearly over six months. The Ignition Sale allocation is 6.67%.